Abstract
Exendin-4 is a 39 amino acid peptide isolated from the Gila monster salivary gland. It is 53% homologous to GLP-1 and exhibits similar glucoregulatory activities. In this study, exendin-4 dimer (D-Ex4) was constructed, cloned into plasmid pET32a(+) and expressed in E. coli BL21(DE3). The fusion protein with His-tag at the N-terminus was purified with a Ni-NTA-agarose column. After proteolytic cleavage, D-Ex4 peptide with high purity was obtained by HPLC. The results obtained by chemical cross-linking showed that D-Ex4 maintained affinity to GLP-1 receptor.
Keywords: Exendin-4 dimer, recombinant expression, purification, chemical cross-linking
Protein & Peptide Letters
Title: Expression and Purification of Exendin-4 Dimer in Escherichia coli and Its Interaction with GLP-1 Receptor In Vitro
Volume: 13 Issue: 8
Author(s): Lina Yi, Xiaopu Yin, Dongzhi Wei and Yushu Ma
Affiliation:
Keywords: Exendin-4 dimer, recombinant expression, purification, chemical cross-linking
Abstract: Exendin-4 is a 39 amino acid peptide isolated from the Gila monster salivary gland. It is 53% homologous to GLP-1 and exhibits similar glucoregulatory activities. In this study, exendin-4 dimer (D-Ex4) was constructed, cloned into plasmid pET32a(+) and expressed in E. coli BL21(DE3). The fusion protein with His-tag at the N-terminus was purified with a Ni-NTA-agarose column. After proteolytic cleavage, D-Ex4 peptide with high purity was obtained by HPLC. The results obtained by chemical cross-linking showed that D-Ex4 maintained affinity to GLP-1 receptor.
Export Options
About this article
Cite this article as:
Yi Lina, Yin Xiaopu, Wei Dongzhi and Ma Yushu, Expression and Purification of Exendin-4 Dimer in Escherichia coli and Its Interaction with GLP-1 Receptor In Vitro, Protein & Peptide Letters 2006; 13(8) . https://dx.doi.org/10.2174/092986606777841226
DOI https://dx.doi.org/10.2174/092986606777841226 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Editorial [Hot topic:The Two Faces of High-Density Lipoprotein (Executive Editor: Sophie Van Linthout)]
Current Pharmaceutical Design Subject Index to Volume 3
Current Gene Therapy Neurohypophyseal Dysfunction During Septic Shock
Endocrine, Metabolic & Immune Disorders - Drug Targets FMRI of the Emotions: Towards an Improved Understanding of Amygdala Function
Current Medical Imaging Polyethylene Glycol Acts as a Mechanistic Stabilizer of L-asparaginase: A Computational Probing
Medicinal Chemistry Pharmacologic Treatment for Prehypertension: To Treat or Not to Treat?
Recent Patents on Cardiovascular Drug Discovery Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System
CNS & Neurological Disorders - Drug Targets Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
Mini-Reviews in Medicinal Chemistry Use and Results of Antidepressant Treatment: Patients' Perception
Current Drug Therapy Hypothalamic AMP-activated Protein Kinase as a Regulator of Food Intake and Energy Balance
CNS & Neurological Disorders - Drug Targets A Pyridinium-substituted Analog of the TRH-like Tripeptide pGlu-Glu- Pro-NH2 and its Prodrugs as Central Nervous System Agents
Medicinal Chemistry Direct and Rapid Transcript Analysis Assay for CYP mRNA Expression and Inducibility in Human Primary Hepatocytes
Drug Metabolism Letters A New Short Validated U-HPLC Method for the Determination of Recombinant Human Insulin in Microspheres
Current Pharmaceutical Analysis Targeting Nrf2 in Protection Against Renal Disease
Current Medicinal Chemistry Effects of Melatonin on Peripheral Nerve Regeneration
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Alternative Routes of Administration as an Approach to Improve Insulin Therapy: Update on Dermal, Oral, Nasal and Pulmonary Insulin Delivery
Current Pharmaceutical Design Patent Selections:
Recent Patents on Regenerative Medicine Idiosyncratic Drug Hepatotoxicity: Strategy for Prevention and Proposed Mechanism
Current Medicinal Chemistry The Emerging Role of Stem Cells in Regenerative Dentistry
Current Gene Therapy New Targets for Treating the Underlying Pathophysiology and Nonmotor Aspects of Parkinson's Disease
CNS & Neurological Disorders - Drug Targets